ZICHEM PHARMA
0431.802.725 · rovalta.com · 24/09/2026
ACTIVE
ZICHEM PHARMA
Financial year 2025 · Closed on 31/12/2025
Net result40,3 k €+67,9 %over 1 year
Gross margin52,2 k €+71,8 %over 1 year
Equity538,2 k €+8,1 %over 1 year
Overview
Identity
Source · BCE/KBOZICHEM PHARMA is a Private limited company incorporated in 1987. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Scherpenheuvel-Zichem.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0431.802.725
- Incorporation
- 21/08/1987
- Legal form
- Private limited company
- Registered office
- Markt 7
3271 Scherpenheuvel-Zichem · FlandreSee on map - Contributed capital
- 7 105,33 €
- Latest accounts
- 31/12/2025
Activities (NACE)
Joint committees (2)
- 218
- 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 20 filingsTrend over 15 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 52,2 k € | +71.8% | 30,4 k € | -58.9% | 74 k € | -12.2% | 84,3 k € | +38.1% | 61 k € |
| EBITDA | 50,2 k € | +75.1% | 28,6 k € | -59.3% | 70,3 k € | -14.4% | 82,2 k € | +38.7% | 59,2 k € |
| Operating result | 43,8 k € | +128% | 19,2 k € | -68.9% | 61,8 k € | -17.1% | 74,5 k € | +39.5% | 53,4 k € |
| Net result | 40,3 k € | +67.9% | 24 k € | -56.5% | 55,1 k € | -6.5% | 58,9 k € | +40.5% | 41,9 k € |
| Balance sheet | |||||||||
| Equity | 538,2 k € | +8.1% | 498 k € | +5.1% | 474 k € | +13.1% | 418,9 k € | +16.4% | 360 k € |
| Total assets | 622,4 k € | +5.9% | 587,7 k € | -3.3% | 607,7 k € | +24.6% | 487,9 k € | +16.7% | 418,1 k € |
| Cash | 4,1 k € | -26.0% | 5,6 k € | +12.2% | 5 k € | -30.7% | 7,2 k € | +46.0% | 4,9 k € |
| Debts | 84,2 k € | -6.2% | 89,7 k € | -32.9% | 133,7 k € | +93.9% | 68,9 k € | +18.7% | 58,1 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20253 active · 16 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 12/05/2026 | 16/06/2025 | 12/06/2024 | 09/06/2023 | 07/06/2022 | 14/06/2021 |
| General meeting | 02/05/2026 | 02/05/2025 | 03/05/2024 | 05/05/2023 | 06/05/2022 | 07/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 02/05/2026 | 12/05/2026 | Dutch | |
| Abridged model | 31/12/2024 | 02/05/2025 | 16/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 03/05/2024 | 12/06/2024 | Dutch | |
| Abridged model | 31/12/2022 | 05/05/2023 | 09/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 06/05/2022 | 07/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 07/05/2021 | 14/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 02/05/2020 | 14/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 03/05/2019 | 09/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 04/05/2018 | 28/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 05/05/2017 | 10/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 06/05/2016 | 13/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 02/05/2015 | 27/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 27/06/2014 | 26/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 28/06/2013 | 28/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 10/10/2012 | 16/10/2012 | Dutch | |
| Abridged model | 31/12/2010 | 28/06/2011 | 21/02/2012 | Dutch | |
| Abridged model | 31/12/2009 | 26/06/2010 | 22/03/2011 | Dutch | |
| Abridged model | 31/12/2008 | 26/06/2009 | 18/09/2009 | Dutch | |
| Abridged model | 31/12/2007 | 26/06/2008 | 04/09/2009 | Dutch | |
| Abridged model | 31/12/2006 | 25/06/2007 | 04/09/2009 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20253 active · 16 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates12/08/2026Ontslag en benoeming bestuurder
- Mandates01/12/2022ONTSLAGEN - BENOEMINGEN
- Mandates07/01/2021WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
- Mandates14/12/2016ONTSLAGEN - BENOEMINGEN
- Mandates14/07/2016ONTSLAGEN - BENOEMINGEN
- Mandates05/05/2015BENAMING - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - WIJZIGING RECHTSVORM
- Mandates19/11/2012ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202540,3 k €↑
- 2024Annual accounts 202424 k €↓
- 2024Name change035 - Zichem Pharma
- 2023Annual accounts 202355,1 k €↓
- 2022Annual accounts 202258,9 k €↑
- 2021Annual accounts 202141,9 k €↑
- 2021Name changeZichem Pharma
- 2020Annual accounts 202038,6 k €↑
- 2019Annual accounts 201914,3 k €↓
- 2018Annual accounts 201829,7 k €↑
- 2017Annual accounts 20175,7 k €↓
- 2016Annual accounts 201618,2 k €↑
- 2015Annual accounts 201512,4 k €↓
- 2014Annual accounts 201462,7 k €↑
- 2013Annual accounts 2013-39 k €↓
- 2012Annual accounts 2012-30,6 k €↓
- 2011Annual accounts 2011-2,5 k €
- 21/08/1987IncorporationPrivate limited company